INTERNATIONAL ISOTOPES INC. ANNOUNCES 2021 YEAR END FINANCIAL RESULTS

Steve Laflin, Chief Executive Officer of the Company, stated, "We continued to see an improvement in all of our business segments financial performance during the past year.  The coronavirus (COVID-19) pandemic has continued to have a negative impact on our business sales in 2021, but in spite of that we still achieved the highest annual revenue for the Company in three years.  We believe we will continue to see significant recovery of markets, patient treatment schedules, and our product sales in 2022.  We will continue to promote sales of our sodium iodide product, and aggressively launch new products within the nuclear medicine standards business segment.  The recent increase in the amount of cobalt available from the Department of Energy (DOE) will continue to facilitate further increases in our cobalt product sales in the coming year.  We believe that the combination of improving market conditions, following the decline in COVID-19 cases, coupled with our growth projections for each of our business segments, should lead to excellent financial performance for the Company in 2022 and beyond."

International Isotopes Inc. Safe Harbor Statement
Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements with respect to revenue expectations for the future within our business segments, our ability to launch new products, and the impact of the novel coronavirus (COVID-19) on our business. Information contained in such forward-looking statements is based on current expectations and is subject to change.  These statements involve several risks, uncertainties and other factors that could cause actual results, performance or achievements of International Isotopes Inc. to be materially different from any future results, performance or achievements of the Company expressed or implied by these forward-looking statements.  Other factors, which could materially affect such forward-looking statements, can be found in the Company's filings with the Securities and Exchange Commission at www.sec.gov, including its Annual Report on Form 10-K for the year ended December 31, 2021.  Investors, potential investors, and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

FOR MORE INFORMATION, CONTACT:

David Drewitz
Creative Options Communications
Investor and Public Relations
david@creativeoptionscommunications.com 
www.creativeoptionsmarketing.com   
Phone:  972-814-5723

View original content:https://www.prnewswire.com/news-releases/international-isotopes-inc-announces-2021-year-end-financial-results-301516954.html

SOURCE International Isotopes Inc.